SOURCE: National Comprehensive Cancer Network

National Comprehensive Cancer Network

September 15, 2014 12:00 ET

Patient-Friendly Guide Offers Free Step-by-Step Information for People With Soft Tissue Sarcoma

NCCN Guidelines for Patients®: Soft Tissue Sarcoma, Available Free-of-Charge at, Is Designed to Provide People With Cancer and Their Caregivers State-of-the-Art Treatment Information in Easy-to-Understand Language

FORT WASHINGTON, PA--(Marketwired - September 15, 2014) - People with various soft tissue sarcoma diagnoses need access to state-of-the-art treatment information in easy-to-understand language. The National Comprehensive Cancer Network® (NCCN®) has published the NCCN Guidelines for Patients®: Soft Tissue Sarcoma for people with various soft tissue sarcoma diagnoses, including sarcomas of the limbs, outer trunk, head, and neck; sarcomas of the inner trunk; gastrointestinal stromal tumors; and desmoid tumors.

The NCCN Guidelines for Patients®: Soft Tissue Sarcoma, through the support of the NCCN Foundation®, is available to view and download free-of-charge at

"NCCN is pleased to offer the NCCN Guidelines for Patients: Soft Tissue Sarcoma," said Marcie R. Reeder, MPH, Executive Director, NCCN Foundation. "Considering that sarcomas are rare tumor types, the availability of such a valuable patient information resource indeed empowers patients and their caregivers through knowledge, allowing them to work alongside their care teams to make informed treatment decisions."

The NCCN Guidelines for Patients®, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), are designed to provide people with cancer and their caregivers state-of-the-art treatment information in easy-to-understand language.

The NCCN Guidelines® are developed by multidisciplinary panels of experts from NCCN Member Institutions and feature algorithms that address appropriate management options from initial work-up throughout the course of the disease. The NCCN Guidelines for Patients® translate the professional guidelines in a clear, step-by-step manner that people can use as the basis for discussing treatment options with their physicians.

This resource is written according to plain language principles to improve health literacy, and the design and format feature patient-friendly elements such as medical illustrations alongside descriptions of body parts, tests, and treatments. NCCN Guidelines for Patients®: Soft Tissue Sarcoma also includes an expansive glossary with definitions of medical terms and acronyms.

NCCN currently offers NCCN Guidelines for Patients for the following: Breast, Colon, Esophageal, Non-Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Caring for Adolescents and Young Adults (AYA); Chronic Myelogenous Leukemia; Lung Cancer Screening, Malignant Pleural Mesothelioma; Melanoma, Multiple Myeloma; and Soft Tissue Sarcoma.

Funding for the library of NCCN Guidelines for Patients is made possible through the NCCN Foundation.

To download the NCCN Guidelines for Patients®: Soft Tissue Sarcoma, visit

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 25 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.

The NCCN Member Institutions are: Fred and Pamela Buffett Cancer Center at The Nebraska Medical Center, Omaha, NE; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.

Clinicians, visit Patients and caregivers, visit

The following files are available for download:

Contact Information